Jeff Hunnicutt Will Join Highlands Oncology on October 1st as Their First Chief Executive Officer Highlands Oncology is excited to announce Jeff Hunnicutt as their very first CEO. Jeff has 13 years of experience in healthcare, all being in the field of oncology. Jeff...
The research department at Highlands Oncology Group in Rogers and Fayetteville was part of a recent clinical trial, leading to a new drug that treats breast cancer. The drug, Kisqali, was developed by Novartis and been approved by the U.S. Food and Drug...
